From Medscape Rheumatology

Coverage from the

American College of Rheumatology (ACR) 2022 Annual Meeting

November 10 - 14, 2022; Philadelphia, Pennsylvania

November 10 - 14, 2022 Philadelphia, Pennsylvania

ACR 2022 First Classification Criteria Proposed for Chronic Osteomyelitis The disease and its more severe form, chronic recurrent multifocal osteomyelitis, have been diagnosed by exclusion, which can delay treatment and referral.
Medscape Medical News, November 18, 2022
ACR 2022 Retention High With Biosimilar-to-Biosimilar Switch for Arthritis Danish investigators studied how a government-mandated switch from one infliximab biosimilar to another affected patients with inflammatory arthritis.
MDedge News, November 14, 2022
ACR 2022 Lower HCQ Dose for Lupus Tied to Hospitalizations for Flares Longer-term HCQ-induced retinopathy risk must be balanced with shorter-term risk for hospitalization for an SLE flare from a lower dose, researchers say.
Medscape Medical News, November 14, 2022

Conference News

ACR 2022 Rheumatology Workforce Shortage Demands Multipronged Approach
Medscape Medical News, December 16, 2022
ACR 2022 Ask Knee OA Patients About Stair Climbing Difficulty
MDedge News, December 7, 2022
ACR 2022 ACR, EULAR Roll Out Updated Antiphospholipid Syndrome Criteria
MDedge News, November 22, 2022
ACR 2022 Sarilumab Effective for Polymyalgia Rheumatica in Phase 3 Trial
Medscape Medical News, November 21, 2022
ACR 2022 Intensive Gout Treatment Meets Urate Goal, Lowers Tophi Burden
Medscape Medical News, November 18, 2022
ACR 2022 First Classification Criteria Proposed for Chronic Osteomyelitis
Medscape Medical News, November 18, 2022
ACR 2022 Denosumab May Halt Erosive Hand Osteoarthritis Progression
MDedge News, November 18, 2022
ACR 2022 Knee OA Pain Eased in Community-Based Weight-Loss Programs
MDedge News, November 18, 2022
ACR 2022 HCQ Doesn't Prevent or Delay Onset of Rheumatoid Arthritis
MDedge News, November 18, 2022
ACR 2022 Opioids Increase Risk for All-Cause Deaths in RA vs. NSAIDs
MDedge News, November 17, 2022

ACR 2022 Combination Therapy May Boost Remission in JIA
MDedge News, November 17, 2022
ACR 2022 Combo Therapy Shows Mixed Results for SSc-Related Lung Disease
MDedge News, November 16, 2022
ACR 2022 Prednisone, Colchicine Equally Efficacious for CPP Arthritis
MDedge News, November 16, 2022
ACR 2022 NSAIDs for Spondyloarthritis May Affect Time to Conception
Medscape Medical News, November 15, 2022
ACR 2022 Retention High With Biosimilar-to-Biosimilar Switch for Arthritis
MDedge News, November 14, 2022
ACR 2022 Lower HCQ Dose for Lupus Tied to Hospitalizations for Flares
Medscape Medical News, November 14, 2022
ACR 2022 Remibrutinib Safe for Sjögren's in Phase 2
Medscape Medical News, November 14, 2022
ACR 2022 CTD-ILD: Rituximab 'a Reasonable Alternative to Cyclophosphamide'
MDedge News, November 13, 2022
ACR 2022 First Recommendations for Cancer Screening in Myositis Issued
MDedge News, November 12, 2022
ACR 2022 Clinical Signs Differ Between Kids and Adults With Vasculitis
Medscape Medical News, November 12, 2022

Medscape Rheumatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Psoriatic Arthritis Highlights From ACR 2022
Philip Mease, MD

Popular News From ACR 2021

Vitamin D and Omega-3 Supplements Reduce Autoimmune Disease Risk The effect was strongest with vitamin D, with significant risk reduction beginning more than 2 years after the start of daily supplementation.
Medscape Medical News, Nov 07, 2021
Tofacitinib Postmarketing Data Shed Light on JAK Inhibitor Risks Analyses of the phase 3b/4 ORAL Surveillance trial results found independent factors for risk for major adverse cardiovascular events, cancer, and venous thromboembolic events.
Medscape Medical News, Nov 17, 2021
Low-Dose Rituximab May Keep RA Activity Low in Responders Rituximab doses as low as 200 mg were effective in treating rheumatoid arthritis, an extension study of a small trial in the Netherlands found.
Medscape Medical News, Nov 19, 2021

Previous Coverage

Related Resources